Connect Biopharma Holdings Ltd financial data

Symbol
CNTB on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 829% %
Debt-to-equity 14% %
Return On Equity -65% %
Return On Assets -57% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55,903,513 shares
Common Stock, Shares, Outstanding 55,786,000 shares
Entity Public Float $45,100,000 USD
Common Stock, Value, Issued $10,000 USD
Weighted Average Number of Shares Outstanding, Basic 55,716,000 shares 0.84%
Weighted Average Number of Shares Outstanding, Diluted 55,716,000 shares 0.84%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $16,000 USD -99%
Research and Development Expense $32,752,000 USD 23%
General and Administrative Expense $20,177,000 USD 8.7%
Operating Income (Loss) $52,167,000 USD -28%
Nonoperating Income (Expense) $3,166,000 USD -48%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $49,001,000 USD -34%
Income Tax Expense (Benefit) $276,000 USD 7%
Net Income (Loss) Attributable to Parent $49,277,000 USD -34%
Earnings Per Share, Basic 0 USD/shares -35%
Earnings Per Share, Diluted 0 USD/shares -35%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $37,845,000 USD
Cash, Cash Equivalents, and Short-term Investments $54,800,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $17,000 USD
Other Assets, Current $228,000 USD
Assets, Current $62,597,000 USD
Property, Plant and Equipment, Net $3,935,000 USD
Operating Lease, Right-of-Use Asset $737,000 USD
Other Assets, Noncurrent $45,000 USD
Assets $67,361,000 USD
Accounts Payable, Current $1,994,000 USD
Employee-related Liabilities, Current $2,102,000 USD
Accrued Liabilities, Current $8,932,000 USD
Contract with Customer, Liability, Current $165,000 USD
Liabilities, Current $11,427,000 USD
Contract with Customer, Liability, Noncurrent $632,000 USD 56%
Operating Lease, Liability, Noncurrent $445,000 USD
Other Liabilities, Noncurrent $118,000 USD
Liabilities $11,990,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,277,000 USD
Retained Earnings (Accumulated Deficit) $385,726,000 USD
Stockholders' Equity Attributable to Parent $55,371,000 USD -45%
Liabilities and Equity $67,361,000 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $9,959,000 USD -1585%
Net Cash Provided by (Used in) Financing Activities $2,000 USD
Net Cash Provided by (Used in) Investing Activities $20,641,000 USD -323%
Common Stock, Shares Authorized 400,000,000 shares
Common Stock, Shares, Issued 55,786,000 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $30,523,000 USD -462%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $37,845,000 USD -61%
Deferred Tax Assets, Gross $74,972,000 USD 4.4%
Operating Lease, Liability $781,000 USD
Payments to Acquire Property, Plant, and Equipment $81,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $49,972,000 USD -39%
Lessee, Operating Lease, Liability, to be Paid $860,000 USD
Property, Plant and Equipment, Gross $6,676,000 USD 5.9%
Operating Lease, Liability, Current $336,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $354,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $371,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $79,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $30,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $67,822,000 USD 11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 40,000,000 shares 0%
Unrecognized Tax Benefits $1,400,000 USD
Operating Lease, Payments $343,000 USD 39%
Additional Paid in Capital $442,544,000 USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $173,000 USD 5.5%
Share-based Payment Arrangement, Expense $4,210,000 USD -55%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%